Bellevue Life Sciences Acquisition (OSRH) Debt to Equity (2022 - 2026)
Bellevue Life Sciences Acquisition (OSRH) debt to equity from Sep 30, 2022 to Mar 31, 2026. The current Bellevue Life Sciences Acquisition (OSRH) debt to equity is 0.37%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Bellevue Life Sciences Acquisition (OSRH)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 1.83% | -106.61% |
| 2024 | -27.61% | -46.55% |
| 2023 | -51.66% | -98.19% |
| 2022 | -2850.00% | N/A |
Comparison Bellevue Life Sciences Acquisition (OSRH) debt to equity with competitors
Bellevue Life Sciences Acquisition (OSRH) debt to equity is 0.37%.